{"cik":906338,"taxonomy":"us-gaap","tag":"ContractWithCustomerLiabilityCurrent","label":"Contract with Customer, Liability, Current","description":"Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.","entityName":"TARO PHARMACEUTICAL INDUSTRIES LTD","units":{"USD":[{"end":"2018-03-31","val":223000,"accn":"0001564590-19-022978","fy":2019,"fp":"FY","form":"20-F","filed":"2019-06-20","frame":"CY2018Q1I"},{"end":"2019-03-31","val":9439000,"accn":"0001564590-19-022978","fy":2019,"fp":"FY","form":"20-F","filed":"2019-06-20"},{"end":"2019-03-31","val":9439000,"accn":"0001564590-20-029846","fy":2020,"fp":"FY","form":"20-F","filed":"2020-06-19","frame":"CY2019Q1I"},{"end":"2020-03-31","val":237000,"accn":"0001564590-20-029846","fy":2020,"fp":"FY","form":"20-F","filed":"2020-06-19"},{"end":"2020-03-31","val":237000,"accn":"0001564590-21-033341","fy":2021,"fp":"FY","form":"20-F","filed":"2021-06-17","frame":"CY2020Q1I"},{"end":"2021-03-31","val":7583000,"accn":"0001564590-21-033341","fy":2021,"fp":"FY","form":"20-F","filed":"2021-06-17"},{"end":"2021-03-31","val":7583000,"accn":"0000950170-22-012998","fy":2022,"fp":"FY","form":"20-F","filed":"2022-07-25","frame":"CY2021Q1I"},{"end":"2022-03-31","val":5788000,"accn":"0000950170-22-012998","fy":2022,"fp":"FY","form":"20-F","filed":"2022-07-25"},{"end":"2022-03-31","val":5788000,"accn":"0000950170-23-030778","fy":2023,"fp":"FY","form":"20-F","filed":"2023-06-29","frame":"CY2022Q1I"},{"end":"2023-03-31","val":903000,"accn":"0000950170-23-030778","fy":2023,"fp":"FY","form":"20-F","filed":"2023-06-29","frame":"CY2023Q1I"}]}}